Panacea Biotec launches ‘Polprotec’ in Nigeria

22 Feb 2012 Evaluate

Panacea Biotec, India's leading vaccine manufacturer has launched Polprotec, an enhanced potency, inactivated poliovirus vaccine in Nigeria in collaboration with Emzor Pharma, Nigeria.

Further, Panacea Biotec and Emzor have together unveiled their joint planet Polio-Free mission statement to contribute towards achieving the goal of global polio eradication and to ensure that no child will ever again be paralyzed by WPV or Vaccine-Derived Polio Virus (VDPV). For this they will provide a complete portfolio of Oral Polio Vaccines (OPV), Inactivated Polio Vaccine (IPV) and IPV based combination vaccine at an affordable price.

Polprotec was launched by President of Pediatric Association of Nigeria (PAN) in PANCONF 2012. Over 200 pediatricians from all over Nigeria attended the conference.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

429.45 -22.60 (-5.00%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.